To achieve this objective, we investigated whether AIF-1 expression in tumor tissue samples from patients with NSCLC was associated with CD68 expression (a marker of monocytes such as macrophages), IL-6 expression, VEGF expression and clinicopathological features of aggressive tumor behavior. Here, CD68 is linked to neoplasm.